发明公开
EP2710002A1 POLYMORPH FORM OF 4-{[4-({[4-(2,2,2-TRIFLUOROETHOXY)-1,2-BENZISOXAZOL-3-YL]OXY}METHYL)PIPERIDIN-1-YL]METHYL}-TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID
有权
多晶型VON 4 - {[4 - ({[4-(2,2,2-三氟甲基)-1,2-苯并咪唑-3-基] - 氧代 - ]甲基 - )哌啶-1-基]甲基] }四氢-2H-吡喃-4-CARBONSÄURE
- 专利标题: POLYMORPH FORM OF 4-{[4-({[4-(2,2,2-TRIFLUOROETHOXY)-1,2-BENZISOXAZOL-3-YL]OXY}METHYL)PIPERIDIN-1-YL]METHYL}-TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID
- 专利标题(中): 多晶型VON 4 - {[4 - ({[4-(2,2,2-三氟甲基)-1,2-苯并咪唑-3-基] - 氧代 - ]甲基 - )哌啶-1-基]甲基] }四氢-2H-吡喃-4-CARBONSÄURE
-
申请号: EP12786698.6申请日: 2012-05-18
-
公开(公告)号: EP2710002A1公开(公告)日: 2014-03-26
- 发明人: NUMATA, Toyoharu , NOGUCHI, Hirohide , WAIZUMI, Nobuaki , KOJIMA, Takashi
- 申请人: RaQualia Pharma Inc
- 申请人地址: 2, Aza 5-gochi Taketoyo-cho Chita-gun, Aichi 470 2341 JP
- 专利权人: RaQualia Pharma Inc
- 当前专利权人: RaQualia Pharma Inc
- 当前专利权人地址: 2, Aza 5-gochi Taketoyo-cho Chita-gun, Aichi 470 2341 JP
- 代理机构: Teipel, Stephan
- 优先权: JP2011111901 20110518
- 国际公布: WO2012157288 20121122
- 主分类号: C07D413/14
- IPC分类号: C07D413/14 ; A61K31/454 ; A61P43/00
摘要:
The present invention relates to novel crystal forms of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid. More particularly, the invention relates to polymorph forms (Polymorph Form I or Polymorph Form II), and to processes for the preparation of, compositions containing and to uses of, such polymorph forms.
公开/授权文献
信息查询